Diabetic neuropathy is not associated with homocysteine, folate, vitamin B12 levels, and MTHFR C677T mutation in type 2 diabetic outpatients taking metformin
Autor: | Elisabetta L. Romeo, Fiorella Forte, R. Zingale, Domenico Cucinotta, Giuseppina T. Russo, Angela Alibrandi, N. Gambadoro, Annalisa Giandalia, C. Scarcella, Giuseppa Perdichizzi |
---|---|
Rok vydání: | 2015 |
Předmět: |
Male
Diabetic neuropathy Endocrinology Diabetes and Metabolism Type 2 diabetes Diabetic neuropathy Type 2 diabetes Metformin Homocysteine Vitamin B12 MTHFR 0302 clinical medicine Endocrinology Diabetic Neuropathies Outpatients Homocysteine Aged 80 and over education.field_of_study biology Middle Aged Prognosis Metformin Vitamin B 12 Female medicine.drug Adult medicine.medical_specialty Hyperhomocysteinemia Genotype Population 030209 endocrinology & metabolism 03 medical and health sciences Folic Acid Internal medicine Diabetes mellitus medicine Humans Hypoglycemic Agents Vitamin B12 education Methylenetetrahydrofolate Reductase (NADPH2) Aged business.industry nutritional and metabolic diseases medicine.disease Cross-Sectional Studies Diabetes Mellitus Type 2 Methylenetetrahydrofolate reductase Mutation MTHFR biology.protein business 030217 neurology & neurosurgery Dyslipidemia Follow-Up Studies |
Zdroj: | Journal of Endocrinological Investigation. 39:305-314 |
ISSN: | 1720-8386 |
DOI: | 10.1007/s40618-015-0365-9 |
Popis: | Hyperhomocysteinemia and vitamin B12 deficiency may be involved in the development of diabetic peripheral neuropathy (DPN). Metformin therapy may reduce vitamin B12 plasma levels, thus contributing to DPN. The purposes of this cross-sectional study were to assess (1) the potential associations of DPN with serum levels of homocysteine (tHcy), B-vitamins, and/or the common methylenetetrahydrofolate reductase (MTHFR) C677T mutation; (2) the influence of chronic treatment with metformin on tHcy and B-vitamins concentrations and, finally, (3) to evaluate whether, by this influence, metformin is a risk factor for DPN in a group of type 2 diabetic outpatients. Our data showed that fasting tHcy, folate, and vitamin B12 levels and the MTHFR C677T genotype distribution were comparable between subjects with (n = 79, 30 %) and without DPN (n = 184, 70 %). Metformin-treated subjects (n = 124, 47 %) showed significantly lower levels of vitamin B12 (P |
Databáze: | OpenAIRE |
Externí odkaz: |